Each group got the same amount of food, calories, and macronutrients (we are not here to fight the macronutrient wars, we arent that brave), but one group ate their food over 3 meals while the other was over six
Big updates are coming out around GLP-1 medications and the conversation is expanding way beyond weight loss
The Role of Brain-Reactive Autoantibodies in Brain Pathology and Cognitive Impairment
Follow her work at @integrativedrmom and healthybydrjen.com
"The percent of employers covering GLP-1s for conditions other than diabetes will stagnate as employers try to stabilize their health care costs, while more of those that cover these medications for weight loss will require utilization management, prescriptions from specific providers, participation in a weight management program and higher expectations from vendor partners to deliver sustainable, cost-effective financial models for this class of medications," The Business Group on Health said in a report last August